Ann Thorac Surg 2009;88:964-965. doi:10.1016/j.athoracsur.2009.06.014
© 2009 The Society of Thoracic Surgeons
Original Articles: General Thoracic
Invited Commentary
Susan Moffatt-Bruce, MD, PhD
Division of Cardiothoracic Surgery, The Ohio State University Medical Center, N835 Doan Hall, 410 W 10th Ave, Columbus, OH 43210
(Email: susan.moffatt-bruce@osumc.edu).
| The first 20% of the full text of this article appears below. |
Lung transplantation is the ultimate therapy for advanced lung disease. The first lung transplant was performed more than 2 decades ago, and since that time, our technical and immunosuppressive expertise has improved. First-year survival statistics have improved, whereby more than 75% of recipients are expected to be alive after 1 year [1]. However, the International Society of Heart and Lung Transplantation Registry reveals that only 51% of patients are alive at 5 years, and even . . . [Full Text of this Article]
Copyright © 2009 by The Society of Thoracic Surgeons.